These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 29630548

  • 1. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
    van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP.
    J Alzheimers Dis; 2018; 63(2):515-527. PubMed ID: 29630548
    [Abstract] [Full Text] [Related]

  • 2. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    Horvath A, Quinlan P, Eckerström C, Åberg ND, Wallin A, Svensson J.
    J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
    [Abstract] [Full Text] [Related]

  • 3. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M, Manera AL, Ducharme S, Collins DL.
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [Abstract] [Full Text] [Related]

  • 4. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    Wang YL, Chen W, Cai WJ, Hu H, Xu W, Wang ZT, Cao XP, Tan L, Yu JT, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2020 Mar; 73(2):759-768. PubMed ID: 31839612
    [Abstract] [Full Text] [Related]

  • 5. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ, Dadar M, Collins DL, Tartaglia MC.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [Abstract] [Full Text] [Related]

  • 6. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
    Kamal F, Morrison C, Maranzano J, Zeighami Y, Dadar M.
    Geroscience; 2023 Feb; 45(1):1-16. PubMed ID: 36229760
    [Abstract] [Full Text] [Related]

  • 7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C, Labriola C, Sugarman MA, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Stein TD, Kowall NW, McKee AC, Mez J, Killiany RJ, Stern RA, Alosco ML.
    Alzheimers Res Ther; 2019 Jul 27; 11(1):64. PubMed ID: 31351489
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A, Foo HJL, Lim JKW, Chander RJ, Yong TT, Ng ASL, Hameed S, Ting SKS, Zhou J, Kandiah N.
    J Alzheimers Dis; 2018 Jul 27; 66(2):533-549. PubMed ID: 30320575
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD163-Mediated Small-Vessel Injury in Alzheimer's Disease: An Exploration from Neuroimaging to Transcriptomics.
    Chen Y, Lu P, Wu S, Yang J, Liu W, Alzheimer’s Disease Neuroimaging Initiative, Zhang Z, Xu Q.
    Int J Mol Sci; 2024 Feb 14; 25(4):. PubMed ID: 38396970
    [Abstract] [Full Text] [Related]

  • 13. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Caillaud M, Hudon C, Boller B, Brambati S, Duchesne S, Lorrain D, Gagnon JF, Maltezos S, Mellah S, Phillips N, Consortium for the Early Identification of Alzheimer’s Disease-Quebec, Belleville S.
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug 13; 75(7):1382-1392. PubMed ID: 31758692
    [Abstract] [Full Text] [Related]

  • 14. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S, Lipton RB, Harvey DJ, Zammit AR, Ezzati A, Alzheimer's Disease Neuroimaging Initiative.
    J Am Geriatr Soc; 2021 Jul 13; 69(7):1906-1915. PubMed ID: 33891712
    [Abstract] [Full Text] [Related]

  • 15. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A, Ng KP, Chander RJ, Wong B, Kandiah N.
    J Alzheimers Dis; 2019 Jul 13; 70(3):953-964. PubMed ID: 31306121
    [Abstract] [Full Text] [Related]

  • 16. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
    Ogama N, Endo H, Satake S, Niida S, Arai H, Sakurai T.
    J Cachexia Sarcopenia Muscle; 2021 Dec 13; 12(6):2045-2055. PubMed ID: 34585518
    [Abstract] [Full Text] [Related]

  • 17. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.
    Rane S, Owen J, Hippe DS, Cholerton B, Zabetian CP, Montine T, Grabowski TJ.
    J Neuroimaging; 2020 Nov 13; 30(6):843-850. PubMed ID: 32937003
    [Abstract] [Full Text] [Related]

  • 18. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm.
    Tubi MA, Feingold FW, Kothapalli D, Hare ET, King KS, Thompson PM, Braskie MN, Alzheimer’s Disease Neuroimaging Initiative.
    Neuroimage; 2020 Feb 01; 206():116327. PubMed ID: 31682983
    [Abstract] [Full Text] [Related]

  • 19. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G, Mouiha A, Duchesne S, Bocti C, Alzheimer's Disease Neuroimaging Initiative1.
    J Alzheimers Dis; 2015 Feb 01; 46(4):855-62. PubMed ID: 26402625
    [Abstract] [Full Text] [Related]

  • 20. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M, Doshi J, Nabavizadeh SA, Toledo JB, Erus G, Xie SX, Trojanowski JQ, Han X, Davatzikos C.
    J Alzheimers Dis; 2015 Feb 01; 48(4):987-94. PubMed ID: 26402108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.